ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

WSJ BLOG/Health: A.M. Vitals: Justices Question Health Law

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.) By Stefanie Ilgenfritz Here's what's making health news this morning: Justices Question Health Law (WSJ): The Supreme Court's conservative justices sharply challenged the Obama administration's health-care overhaul Tuesday, raising the prospect that the law could be struck down, while the liberal and conservative wings seemed inclined to split evenly over the question of whether the "individual mandate" is constitutional. Health Executives Unfazed by Debate (WSJ): Insurance companies and hospital chains brushed off concerns Tuesday the Supreme Court could strike down a requirement in the health-care law that would create millions of newly insured customers. In Real World, Mandate Stirs Some Dissent (NYT): Massachusetts offers a real-world laboratory of how a health-insurance mandate might work. Data Show Lower Risk for Bypass Than Stent (WSJ): For patients facing a choice between bypass surgery and a popular, less-invasive procedure to treat heart blockages, surgery improves chances of long-term survival, researchers said Tuesday. Va. Man Injured in Gun Accident Gets New Face (USAT): A 37-year-old U.S. man injured in a 1997 gun accident has received what doctors say is the most extensive face transplant ever performed. Cancer Research Targets a Key Cell Protein (LAT): Blocking "don't destroy me" signals that normally sit on the surface of tumor cells and render them resistant to immune-cell attack slows the growth of a broad range of human cancers when they're implanted in mice, researchers have found. FDA Approves Drug to Treat Anemia (Dow Jones): The Affymax Inc. drug, which will be sold under the brand name Omontys, would compete with Amgen Inc.'s Epogen, which is approved for use in the same group of patients. Defibrillator Wires Linked to Fatalities (WSJ): Heart-defibrillator wires made by St. Jude Medical Inc. are responsible for at least 20 deaths because of "high-voltage failures," according to an analysis published online in a cardiac-medicine journal. -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
05/10/201311:47:11Medicare Overpaid $529 Million for Anemia Drugs in 2011 - Report
05/09/201317:50:29Amgen Forms China Joint Venture
05/09/201317:39:11Amgen Forms China Joint Venture With Zhejiang Beta Pharma
05/07/201317:40:22Amgen Trial of Colon Cancer Drug Meets Goal
05/07/201317:29:37Amgen Late-Stage Trial of Colon Cancer Drug Meets Goal
04/29/201315:04:16Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million...
04/26/201309:42:31As Biotechnology Stocks Soar, Bubble Talk Percolates
04/24/201309:04:55U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
04/23/201319:00:18Amgen Sales Disappoint as Profits Jump 21%
04/23/201316:50:54Amgen First-Quarter Profit Up 21%; Prolia Sales Leap
04/23/201313:11:46MARKET SNAPSHOT: Apple, Caterpillar: Shocked Stocks Get New Test
04/18/201313:08:13Merck CEO Pay Rises but Still Nicked by Research Setbacks
04/16/201317:30:14Amgen to Pay $24.9 Million to Settle Kickbacks Allegations
04/16/201317:23:12Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks
03/20/201311:03:57Model N Shares Rise After IPO
02/27/201311:20:08U.S. Supreme Court Rejects Amgen Challenge to Suit
02/27/201310:48:32U.S. Supreme Court Rejects Amgen Challenge to Securities Suit
02/26/201314:07:10FDA Stops Pediatric Studies of Amgen's Sensipar After Death
02/14/201312:25:30Affymax Shares Fall as Customer Pauses Pilot Drug Program
02/07/201308:51:11Amgen Raises 2013 Earnings View on Tax-Charge Adjustment

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad